Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jfma.2025.04.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comment on "PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer".
Clin Transl Radiat Oncol
November 2025
Dr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India.
The recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5-year local control rate of 86 % and progressive reduction in SUVmax values across follow-up intervals [1]. While the findings reinforce the utility of PSMAPET/CT as a potential biomarker for local tumor control, certain methodological and interpretive issues merit deeper consideration.
View Article and Find Full Text PDFPercutaneous Ablative Techniques in Primary Hyperparathyroidism: Not All Glands are Created Equal.
J Clin Endocrinol Metab
July 2025
Division of Endocrinology, Dept of Medicine, Columbia University College of Physicians and Surgeons, New York NY, USA.
Reply to comment on "Ablative margin assessment for recurrence prediction in patients with hepatocellular carcinoma receiving radiofrequency ablation".
J Formos Med Assoc
May 2025
Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan, Republic of China; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan, Republic of China; Center of Minimal-Invasive Interventional Radiology, National Taiwan University Hospital, Taipei,
To irradiate or electroporate: how should we ablate pancreatic cancer?
Transl Gastroenterol Hepatol
April 2025
Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Comment on "Ablative margin assessment for recurrence prediction in patients with hepatocellular carcinoma receiving radiofrequency ablation".
J Formos Med Assoc
May 2025
The Second Clinical Medical College, Zhejiang Chinese Medical University, China. Electronic address: